HEXB and Salla disease: Here, we employ a BMT + CSF1Ri-based microglial replacement strategy in the Hexb-/- mouse model of SD and demonstrate that delivery of Hexb-expressing cells via myeloid cell replacement rescues neuron-related molecular and functional outcomes.